Application Nr Approved Date Route Status External Links
ANDA203860 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Sevelamer Carbonate Is Indicated For The Control Of Serum Phosphorus In Adults With Chronic Kidney Disease (Ckd) On Dialysis Pediatric Use Information Is Approved For Genzyme Corporation’s Renvela (Sevelamer Carbonate) Tablets. However, Due To Genzyme Corporation’s Marketing Exclusivity Rights, This Drug Product Is Not Labeled With That Pediatric Information Sevelamer Carbonate Is A Phosphate Binder Indicated For The Control Of Serum Phosphorus In Adults With Chronic Kidney Disease On Dialysis. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Sevelamer Carbonate SEVELAMER CARBONATE ZINC2016052

Comments